Limited infection upon human exposure to a recombinant raccoon pox vaccine vector
Vaccine
Links
- More Information:
- Download citation as: RIS | Dublin Core
Abstract
A laboratory accident resulted in human exposure to a recombinant raccoon poxvirus (RCN) developed as a vaccine vector for antigens of Yersinia pestis for protection of wild rodents (and other animals) against plague. Within 9 days, the patient developed a small blister that healed within 4 weeks. Raccoon poxvirus was cultured from the lesion, and the patient developed antibody to plague antigen (F1) and RCN. This is the first documented case of human exposure to RCN.
| Publication type | Article |
|---|---|
| Publication Subtype | Journal Article |
| Title | Limited infection upon human exposure to a recombinant raccoon pox vaccine vector |
| Series title | Vaccine |
| DOI | 10.1016/j.vaccine.2004.01.030 |
| Volume | 22 |
| Issue | 21-22 |
| Year Published | 2004 |
| Language | English |
| Publisher | Elsevier |
| Contributing office(s) | National Wildlife Health Center |
| Description | 4 p. |
| First page | 2757 |
| Last page | 2760 |